Influenza and influenza-like illness in general practice: Drawing lessons for surveillance from a pilot study in Paris, France

British Journal of General Practice

Volumn 47, Issue 417, 1997, Pages 217-220

  Carrat, Fabrice ^a  

^a INSERM   (France)

Author keywords

Diagnosis; General practice; Infectious diseases; Influenza

Indexed keywords

ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; INFLUENZA VACCINE;

ABSENTEEISM; ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FRANCE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; IMMUNOFLUORESCENCE; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NOSE SMEAR; SYMPTOM; THROAT CULTURE; WINTER;

ADULT; FAMILY PRACTICE; FEASIBILITY STUDIES; FEMALE; HUMANS; INFLUENZA, HUMAN; MALE; PARIS; PILOT PROJECTS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0030891585     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Cox NJ, Brammer L, Regnery HL. Influenza: global surveillance for epidemic and pandemic variants. Eur J Epidemiol 1994; 10: 467-470.
2. Anonymous. Recommended composition of influenza virus vaccines for use in the 1995-1996 season. WHO Wkly Epidemiol Rec 1995; 70: 53-56.
3. Szecsenyi J, Uphoff H, Brede HD. Influenza surveillance: experiences from establishing a sentinel surveillance system in Germany. J Epidemiol Community Health 1995; 49: 9-13.